Literature DB >> 24333182

Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice.

Xuelian Xiong1, Xiaolin Wang1, Yan Lu1, E Wang1, Zhijian Zhang1, Jian Yang1, Huijie Zhang1, Xiaoying Li2.   

Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is characterized by an increase in hepatic triglyceride (TG) contents. The prevalence of NAFLD is increased with aging. However, the molecular mechanism for aging-induced fatty liver remains poorly understood.
METHODS: Hepatic TG contents and gene expression profiles were analyzed in body weight-matched young (2 months), middle (8 months) and old (18 months) C57BL/6 mice. Endoplasmic reticulum (ER) stress and farnesoid X receptor (FXR) expression were examined. The mechanism of ER stress activation in the regulation of FXR expression was further investigated.
RESULTS: In the present study, we found that TG was markedly accumulated and lipogenic genes were up-regulated in the liver of C57BL/6 mice aged 18 months. FXR, a key regulator of hepatic lipid metabolism was down-regulated in these old mice. At molecular levels, ER stress was activated in old mice and repressed FXR expression through inhibition of hepatocyte nuclear factor 1 alpha (HNF1α) transcriptional activity.
CONCLUSIONS: Our findings demonstrate that FXR down-regulation plays a critical role in aging-induced fatty liver.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Endoplasmic reticulum stress; Farnesoid X receptor; Non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2013        PMID: 24333182     DOI: 10.1016/j.jhep.2013.12.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

1.  Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.

Authors:  Shogo Takahashi; Naoki Tanaka; Srujana Golla; Tatsuki Fukami; Kristopher W Krausz; Marianne A Polunas; Blair C Weig; Yusuke Masuo; Cen Xie; Changtao Jiang; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

2.  Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model.

Authors:  Kiminori Watanabe; Masayuki Ohta; Hiroomi Takayama; Kazuhiro Tada; Yuki Shitomi; Takahide Kawasaki; Yuichiro Kawano; Yuichi Endo; Yukio Iwashita; Masafumi Inomata
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

3.  Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein 1.

Authors:  Nian Liu; Jun Zhao; Jinguo Wang; Haolin Teng; Yaowen Fu; Hang Yuan
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.

Authors:  Kang Ho Kim; Sungwoo Choi; Ying Zhou; Eun Young Kim; Jae Man Lee; Pradip K Saha; Sayeepriyadarshini Anakk; David D Moore
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

Review 5.  FXR agonists as therapeutic agents for non-alcoholic fatty liver disease.

Authors:  Rotonya M Carr; Andrea E Reid
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

Review 6.  Snapshot: implications for melatonin in endoplasmic reticulum homeostasis.

Authors:  Wei Hu; Zhiqiang Ma; Shouyin Di; Shuai Jiang; Yue Li; Chongxi Fan; Yang Yang; Dongjin Wang
Journal:  Br J Pharmacol       Date:  2016-11-16       Impact factor: 8.739

Review 7.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

Authors:  Alessandro Federico; Claudio Zulli; Ilario de Sio; Anna Del Prete; Marcello Dallio; Mario Masarone; Carmela Loguercio
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Trehalose supplementation reduces hepatic endoplasmic reticulum stress and inflammatory signaling in old mice.

Authors:  Michael J Pagliassotti; Andrea L Estrada; William M Hudson; Yuren Wei; Dong Wang; Douglas R Seals; Melanie L Zigler; Thomas J LaRocca
Journal:  J Nutr Biochem       Date:  2017-04-06       Impact factor: 6.048

9.  Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.

Authors:  Yan Lu; Xing Liu; Yang Jiao; Xuelian Xiong; E Wang; Xiaolin Wang; Zhijian Zhang; Huijie Zhang; Lingling Pan; Youfei Guan; Dongsheng Cai; Guang Ning; Xiaoying Li
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

Review 10.  The role of ER stress in lipid metabolism and lipotoxicity.

Authors:  Jaeseok Han; Randal J Kaufman
Journal:  J Lipid Res       Date:  2016-05-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.